457 related articles for article (PubMed ID: 25749014)
1. SAR refinement of antileishmanial N(2),N(4)-disubstituted quinazoline-2,4-diamines.
Zhu X; Van Horn KS; Barber MM; Yang S; Wang MZ; Manetsch R; Werbovetz KA
Bioorg Med Chem; 2015 Aug; 23(16):5182-9. PubMed ID: 25749014
[TBL] [Abstract][Full Text] [Related]
2. Antileishmanial activity of a series of N²,N⁴-disubstituted quinazoline-2,4-diamines.
Van Horn KS; Zhu X; Pandharkar T; Yang S; Vesely B; Vanaerschot M; Dujardin JC; Rijal S; Kyle DE; Wang MZ; Werbovetz KA; Manetsch R
J Med Chem; 2014 Jun; 57(12):5141-56. PubMed ID: 24874647
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents.
Agarwal KC; Sharma V; Shakya N; Gupta S
Bioorg Med Chem Lett; 2009 Sep; 19(18):5474-7. PubMed ID: 19692240
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacological evaluation of mono-arylimidamides as antileishmanial agents.
Zhu X; Farahat AA; Mattamana M; Joice A; Pandharkar T; Holt E; Banerjee M; Gragg JL; Hu L; Kumar A; Yang S; Wang MZ; Boykin DW; Werbovetz KA
Bioorg Med Chem Lett; 2016 May; 26(10):2551-2556. PubMed ID: 27048943
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
[TBL] [Abstract][Full Text] [Related]
6. Identification of a diverse indole-2-carboxamides as a potent antileishmanial chemotypes.
Pandey S; Chauhan SS; Shivahare R; Sharma A; Jaiswal S; Gupta S; Lal J; Chauhan PM
Eur J Med Chem; 2016 Mar; 110():237-45. PubMed ID: 26840364
[TBL] [Abstract][Full Text] [Related]
7. β-Amino acid derivatives as mitochondrial complex III inhibitors of L. donovani: A promising chemotype targeting visceral leishmaniasis.
Chandrakar P; Gunaganti N; Parmar N; Kumar A; Singh SK; Rashid M; Wahajuddin M; Mitra K; Narender T; Kar S
Eur J Med Chem; 2019 Nov; 182():111632. PubMed ID: 31499363
[TBL] [Abstract][Full Text] [Related]
8. Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
Charan Raja MR; Velappan AB; Chellappan D; Debnath J; Kar Mahapatra S
Eur J Med Chem; 2017 Oct; 139():503-518. PubMed ID: 28826085
[TBL] [Abstract][Full Text] [Related]
9. Antileishmanial bis-arylimidamides: DB766 analogs modified in the linker region and bis-arylimidamide structure-activity relationships.
Reid CS; Farahat AA; Zhu X; Pandharkar T; Boykin DW; Werbovetz KA
Bioorg Med Chem Lett; 2012 Nov; 22(22):6806-10. PubMed ID: 22765899
[TBL] [Abstract][Full Text] [Related]
10. Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis.
Gupta S; Yardley V; Vishwakarma P; Shivahare R; Sharma B; Launay D; Martin D; Puri SK
J Antimicrob Chemother; 2015 Feb; 70(2):518-27. PubMed ID: 25389223
[TBL] [Abstract][Full Text] [Related]
11. Discovery and Optimization of Tambjamines as a Novel Class of Antileishmanial Agents.
Kancharla P; Ortiz D; Fargo CM; Zhang X; Li Y; Sanchez M; Kumar A; Yeluguri M; Dodean RA; Caridha D; Madejczyk MS; Martin M; Jin X; Blount C; Chetree R; Pannone K; Dinh HT; DeLuca J; Evans M; Nadeau R; Vuong C; Leed S; Dennis WE; Roncal N; Pybus BS; Lee PJ; Roth A; Reynolds KA; Kelly JX; Landfear SM
J Med Chem; 2024 May; 67(10):8323-8345. PubMed ID: 38722757
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents.
Gopinath VS; Pinjari J; Dere RT; Verma A; Vishwakarma P; Shivahare R; Moger M; Kumar Goud PS; Ramanathan V; Bose P; Rao MV; Gupta S; Puri SK; Launay D; Martin D
Eur J Med Chem; 2013 Nov; 69():527-36. PubMed ID: 24095747
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo antileishmanial efficacy of a new nitrilquinoline against Leishmania donovani.
Nakayama H; Desrivot J; Bories C; Franck X; Figadère B; Hocquemiller R; Fournet A; Loiseau PM
Biomed Pharmacother; 2007; 61(2-3):186-8. PubMed ID: 17360145
[TBL] [Abstract][Full Text] [Related]
15. 4-Arylamino-6-nitroquinazolines: Synthesis and their activities against neglected disease leishmaniasis.
Saad SM; Ghouri N; Perveen S; Khan KM; Choudhary MI
Eur J Med Chem; 2016 Jan; 108():13-20. PubMed ID: 26619389
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antikinetoplastid activity of a series of N,N'-substituted diamines.
Caminos AP; Panozzo-Zenere EA; Wilkinson SR; Tekwani BL; Labadie GR
Bioorg Med Chem Lett; 2012 Feb; 22(4):1712-5. PubMed ID: 22248858
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Plasmodium falciparum Inhibitory Activity, Cytotoxicity and Solubility of N2 ,N4 -Disubstituted Quinazoline-2,4-diamines.
Pobsuk N; Suphakun P; Hannongbua S; Nantasenamat C; Choowongkomon K; Gleeson MP
Med Chem; 2019; 15(6):693-704. PubMed ID: 30569870
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, cytotoxicity, and in vitro antileishmanial activity of mono-t-butyloxycarbonyl-protected diamines.
Pinheiro AC; Rocha MN; Nogueira PM; Nogueira TC; Jasmim LF; de Souza MV; Soares RP
Diagn Microbiol Infect Dis; 2011 Nov; 71(3):273-8. PubMed ID: 21907525
[TBL] [Abstract][Full Text] [Related]
19. Novel arylimidamides for treatment of visceral leishmaniasis.
Wang MZ; Zhu X; Srivastava A; Liu Q; Sweat JM; Pandharkar T; Stephens CE; Riccio E; Parman T; Munde M; Mandal S; Madhubala R; Tidwell RR; Wilson WD; Boykin DW; Hall JE; Kyle DE; Werbovetz KA
Antimicrob Agents Chemother; 2010 Jun; 54(6):2507-16. PubMed ID: 20368397
[TBL] [Abstract][Full Text] [Related]
20. Aminothiazoles: Hit to lead development to identify antileishmanial agents.
Bhuniya D; Mukkavilli R; Shivahare R; Launay D; Dere RT; Deshpande A; Verma A; Vishwakarma P; Moger M; Pradhan A; Pati H; Gopinath VS; Gupta S; Puri SK; Martin D
Eur J Med Chem; 2015 Sep; 102():582-93. PubMed ID: 26318065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
